{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:53:41Z","timestamp":1773057221530,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T00:00:00Z","timestamp":1480896000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["12\/50191-4R"],"award-info":[{"award-number":["12\/50191-4R"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["471340\/2011-1"],"award-info":[{"award-number":["471340\/2011-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["470388\/2010-2"],"award-info":[{"award-number":["470388\/2010-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10456-016-9533-6","type":"journal-article","created":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T00:49:41Z","timestamp":1480898981000},"page":"125-137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["An extracellular proteasome releases endostatin from human collagen XVIII"],"prefix":"10.1007","volume":"20","author":[{"given":"Maria L. V.","family":"Reiss-Pistilli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlef","family":"Schuppan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madalena M. S.","family":"Barroso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iranaia","family":"Assun\u00e7\u00e3o-Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley","family":"Farias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Let\u00edcia","family":"Lery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz","family":"Juliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria A.","family":"Juliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Coelho-Sampaio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,5]]},"reference":[{"key":"9533_CR1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","volume":"88","author":"MS O\u2019Reilly","year":"1997","unstructured":"O\u2019Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277\u2013285","journal-title":"Cell"},{"key":"9533_CR2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/37126","volume":"390","author":"T Boehm","year":"1997","unstructured":"Boehm T, Folkman J, O\u2019Reilly MS (1997) Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390:404\u2013407","journal-title":"Nature"},{"key":"9533_CR3","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1073\/pnas.91.10.4229","volume":"91","author":"SP Oh","year":"1994","unstructured":"Oh SP, Kamagata Y, Muragaki Y, Timmons S, Ooshima A, Olsen BR (1994) Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins. Proc Natl Acad Sci USA 91:4229\u20134233","journal-title":"Proc Natl Acad Sci USA"},{"key":"9533_CR4","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1073\/pnas.91.10.4234","volume":"91","author":"M Rehn","year":"1994","unstructured":"Rehn M, Pihlajaniemi T (1994) Alpha 1 (XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct distribution, and homology with type XV collagen. Proc Natl Acad Sci USA 91:4234\u20134238","journal-title":"Proc Natl Acad Sci USA"},{"key":"9533_CR5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.matbio.2010.11.001","volume":"30","author":"L Seppinen","year":"2011","unstructured":"Seppinen L, Pihlajaniemi T (2011) The multiple functions of collagen XVIII in development and disease. Matrix Biol 30:83\u201392","journal-title":"Matrix Biol"},{"key":"9533_CR6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0002-9440(10)65603-9","volume":"153","author":"J Saarela","year":"1998","unstructured":"Saarela J, Rehn M, Oikarinen A, Autio-Harmainen H, Pihlajaniemi T (1998) The short and long forms of type XVIII collagen show clear tissue specificities in their expressions and location in basement membrane zones in humans. Am J Pathol 153:611\u2013626","journal-title":"Am J Pathol"},{"key":"9533_CR7","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0140-6736(05)60006-2","volume":"352","author":"D Schuppan","year":"1998","unstructured":"Schuppan D, Cramer T, Bauer M, Strefeld T, Hahn EG, Herbst H (1998) Hepatocytes as a source of collagen type XVIII endostatin. Lancet 352:879\u2013880","journal-title":"Lancet"},{"key":"9533_CR8","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1086\/344695","volume":"71","author":"OT Suzuki","year":"2002","unstructured":"Suzuki OT, Serti\u00e9 AL, Der Kaloustian VM, Kok F, Carpenter M, Murray J, Czeizel AE, Kliemann SE, Rosemberg S, Monteiro M, Olsen BR, Passos-Bueno MR (2002) Molecular analysis of collagen XVIII reveals novel mutations, presence of a third isoform, and possible genetic heterogeneity in Knobloch syndrome. Am J Hum Genet 71:1320\u20131329","journal-title":"Am J Hum Genet"},{"key":"9533_CR9","first-page":"6052","volume":"59","author":"W Wen","year":"1999","unstructured":"Wen W, Moses MA, Wiederschain D, Arbiser JL, Folkman J (1999) The generation of endostatin is mediated by elastase. Cancer Res 59:6052\u20136056","journal-title":"Cancer Res"},{"key":"9533_CR10","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/emboj\/19.6.1187","volume":"19","author":"U Felbor","year":"2000","unstructured":"Felbor U, Dreier L, Bryant RA, Plogh HL, Olsen BR, Mothes W (2000) Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J 19:1187\u20131194","journal-title":"EMBO J"},{"key":"9533_CR11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0014-5793(00)02249-3","volume":"486","author":"M Ferreras","year":"2000","unstructured":"Ferreras M, Felbor U, Lenhard T, Olsen BR, Delaiss\u00e9 J (2000) Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett 486:247\u2013251","journal-title":"FEBS Lett"},{"key":"9533_CR12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.yexcr.2005.03.021","volume":"307","author":"R Heljasvaara","year":"2005","unstructured":"Heljasvaara R, Nyberg P, Luostarinen J, Parikka M, Heikkil\u00e4 P, Rehn M, Sorsa T, Salo T, Pihlajaniemi T (2005) Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases. Exp Cell Res 307:292\u2013304","journal-title":"Exp Cell Res"},{"key":"9533_CR13","doi-asserted-by":"crossref","first-page":"37158","DOI":"10.1074\/jbc.M111.284869","volume":"286","author":"F Veillard","year":"2011","unstructured":"Veillard F, Saidi A, Burden RE, Scott CJ, Gillet L, Lecaille F, Lalmanach G (2011) Cysteine cathepsins S and L modulate anti-angiogenic activities of human endostatin. J Biol Chem 286:37158\u201337167","journal-title":"J Biol Chem"},{"key":"9533_CR14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/bbrc.1998.9617","volume":"252","author":"T Bohem","year":"1998","unstructured":"Bohem T, O\u2019Reilly MS, Keough K, Shiloach J, Shapiro R, Folkman J (1998) Zinc-binding of endostatin is essential for its antiangiogenic activity. Biochem Biophys Res Commun 252:190\u2013194","journal-title":"Biochem Biophys Res Commun"},{"key":"9533_CR15","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1158\/0008-5472.CAN-04-1833","volume":"65","author":"RMTT Sjin","year":"2005","unstructured":"Sjin RMTT, Satchi-Fainaro R, Birsner AE, Ramanujam VM, Folkman J, Javaherian K (2005) A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity. Cancer Res 65:3656\u20133663","journal-title":"Cancer Res"},{"key":"9533_CR16","doi-asserted-by":"crossref","first-page":"10443","DOI":"10.1073\/pnas.95.18.10443","volume":"95","author":"YH Ding","year":"1998","unstructured":"Ding YH, Javaherian K, Lo KM, Chopra R, Boehm T, Lanciotti J, Harris BA, Li H, Shapiro R, Hohenester E, Timpl R, Folkman J, Wiley DC (1998) Zinc-dependent dimers observed in crystals of human. Proc Natl Acad Sci USA 95:10443\u201310448","journal-title":"Proc Natl Acad Sci USA"},{"key":"9533_CR17","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.1021\/bi100489x","volume":"49","author":"Y Fu","year":"2010","unstructured":"Fu Y, Luo Y (2010) The N-terminal integrity is critical for the stability and biological functions of endostatin. Biochemistry 49:6420\u20136429","journal-title":"Biochemistry"},{"key":"9533_CR18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-5793(97)01503-2","volume":"420","author":"L St\u00e4ndker","year":"1997","unstructured":"St\u00e4ndker L, Schrader M, Kanse SM, J\u00fcrgens M, Forssmann WG, Preissner KT (1997) Isolation and characterization of the circulating form of human endostatin. FEBS Lett 420:129\u2013133","journal-title":"FEBS Lett"},{"key":"9533_CR19","first-page":"2878","volume":"120","author":"H Hasle","year":"2000","unstructured":"Hasle H, Clemmensen IH, Mikkelsen M (2000) Incidence of cancer in individuals with Down syndrome. Tidsskr Norske Laege 120:2878\u20132881","journal-title":"Tidsskr Norske Laege"},{"key":"9533_CR20","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/sj.ejhg.5200721","volume":"9","author":"TS Zorick","year":"2001","unstructured":"Zorick TS, Mustacchi Z, Bando SY, Zatz M, Moreira-Filho CA, Olsen B, Passos-Bueno MR (2001) High serum endostatin levels in Down syndrome: implications for improved treatment and prevention of solid tumors. Eur J Hum Genet 9:811\u2013814","journal-title":"Eur J Hum Genet"},{"key":"9533_CR21","first-page":"7375","volume":"61","author":"P Iughetti","year":"2001","unstructured":"Iughetti P, Suzuki O, Godoi PH, Alves VA, Serti\u00e9 AL, Zorick T, Soares F, Camargo A, Moreira ES, di Loreto C, Moreira-Filho CA, Simpson A, Oliva G, Passos-Bueno (2001) A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma. Cancer Res 61:7375\u20137378","journal-title":"Cancer Res"},{"key":"9533_CR22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000336109","volume":"35","author":"J Chen","year":"2012","unstructured":"Chen J, Hamm LL, Kleinpeter MA, Husserl F, Khan IE, Chen CS, Liu Y, Mills KT, He C, Rifai N, Simon EE, He J (2012) Elevated plasma levels of endostatin are associated with chronic kidney disease. Am J Nephrol 35:335\u2013340","journal-title":"Am J Nephrol"},{"key":"9533_CR23","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/cncr.10845","volume":"95","author":"AL Feldman","year":"2002","unstructured":"Feldman AL, Alexander HR Jr, Yang JC, Linehan WM, Eyler RA, Miller MS, Steinberg SM, Libutti SK (2002) Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma. Cancer 95:1637\u20131643","journal-title":"Cancer"},{"key":"9533_CR24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.kjms.2011.03.008","volume":"27","author":"MY Hsieh","year":"2011","unstructured":"Hsieh MY, Lin ZY, Chuang WL (2011) Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization. Kaohsiung J Med Sci 27:314\u2013322","journal-title":"Kaohsiung J Med Sci"},{"key":"9533_CR25","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3892\/br.2014.319","volume":"2","author":"MM Hu","year":"2014","unstructured":"Hu MM, Hu Y, Zhang HQ, Jia WY, Qian Z, Yang Y, Li BL (2014) Clinical significance of serum and tumor tissue endostatin evaluation in operable non-small cell lung cancer. Biomed Rep 2:898\u2013904","journal-title":"Biomed Rep"},{"key":"9533_CR26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0169-5002(01)00285-9","volume":"35","author":"M Susuki","year":"2002","unstructured":"Susuki M, Iizasa T, Ko E, Baba M, Saitoh Y, Shibuya K, Sekine Y, Yoshida S, Hiroshima K, Fujisawa T (2002) Serum endostatin correlates with progression and prognosis of non-small cell lung cancer. Lung Cancer 35:29\u201334","journal-title":"Lung Cancer"},{"key":"9533_CR27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00119771","volume":"1","author":"IY Hirata","year":"1994","unstructured":"Hirata IY, Cezari MHS, Nakaie CR, Boschcov P, Ito AS, Juliano MA, Juliano L (1994) Internally quenched fluorogenic protease substrates: solid-phase synthesis and fluorescence spectroscopy of peptides containing ortho-aminobenzoyl\/dinitrophenyl groups as donor-acceptor pairs. Lett Peptide Sci 1:299\u2013308","journal-title":"Lett Peptide Sci"},{"key":"9533_CR28","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/pmic.200500238","volume":"6","author":"WM Kr\u00fcger Von","year":"2006","unstructured":"Von Kr\u00fcger WM, Lery LM, Soares MR, de Neves-Manta FS, Batista e Silva CM, Neves-Ferreira AG, Perales J, Bisch PM (2006) The phosphate-starvation response in Vibrio cholerae O1 and phoB mutant under proteomic analysis: disclosing functions involved in adaptation, survival and virulence. Proteomics 6:1495\u20131511","journal-title":"Proteomics"},{"key":"9533_CR29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1006\/bbrc.2000.3918","volume":"279","author":"MC Lee","year":"2000","unstructured":"Lee MC, Alpaugh ML, Nguyen M, Deato M, Dishakjian L, Barsky SH (2000) Myoepithelial-specific CD44 shedding is mediated by a putative chymotrypsin-like sheddase. Biochem Biophys Res Commun 279:116\u2013123","journal-title":"Biochem Biophys Res Commun"},{"key":"9533_CR30","doi-asserted-by":"crossref","first-page":"33713","DOI":"10.1074\/jbc.R109.018481","volume":"284","author":"A Navom","year":"2009","unstructured":"Navom A, Ciechanover A (2009) The 26 S proteasome: from basic mechanism to drug targeting. J Biol Chem 284:33713\u201333718","journal-title":"J Biol Chem"},{"key":"9533_CR31","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1074\/jbc.270.9.4588","volume":"270","author":"IS Vaithilingam","year":"1995","unstructured":"Vaithilingam IS, McDonald W, Malott DW, Del Maestro RF (1995) An extracellular proteasome-like structure from C6 astrocytoma cells with serine collagenase IV activity and metallo-dependent activity on alpha-casein and beta-insulin. J Biol Chem 270:4588\u20134593","journal-title":"J Biol Chem"},{"key":"9533_CR32","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/40.8.1619280","volume":"40","author":"AJ Rivett","year":"1992","unstructured":"Rivett AJ, Palmer A, Knecht E (1992) Electron microscopic localization of the multicatalytic proteinase complex in rat liver and in culture cells. J Histochem Cytochem 40:1165\u20131172","journal-title":"J Histochem Cytochem"},{"key":"9533_CR33","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.bbadis.2008.06.005","volume":"1782","author":"SU Sixt","year":"2008","unstructured":"Sixt SU, Dahlmann B (2008) Extracellular, circulating proteasomes and ubiquitin - incidence and relevance. Biochim Biophys Acta 1782:817\u2013823","journal-title":"Biochim Biophys Acta"},{"key":"9533_CR34","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1365-2133.2005.06487.x","volume":"152","author":"PE Stoebner","year":"2005","unstructured":"Stoebner PE, Lavabre-Bertrand T, Henry L, Guiraud I, Carillo S, Dandurand M, Joujoux JM, Bureau JP, Meunier L (2005) High plasma proteasome levels are detected in patients with metastatic malignant melanoma. Br J Dermatol 152:948\u2013953","journal-title":"Br J Dermatol"},{"key":"9533_CR35","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/1097-0142(20011115)92:10<2493::AID-CNCR1599>3.0.CO;2-F","volume":"15","author":"T Lavabre-Bertrand","year":"2001","unstructured":"Lavabre-Bertrand T, Henry L, Carillo S, Guiraud I, Ouali A, Dutaud D, Aubry L, Rossi JF, Bureau JP (2001) Plasma proteasome level is a potential marker in patients with solid tumors and hemopoietic malignancies. Cancer 15:2493\u20132500","journal-title":"Cancer"},{"key":"9533_CR36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0022-1759(01)00555-5","volume":"1","author":"D Dutaud","year":"2002","unstructured":"Dutaud D, Aubry L, Henry L, Levieux D, Hendil KB, Kuehn L, Bureau JP, Ouali A (2002) Development and evaluation of a sandwich ELISA for quantification of the 20S proteasome in human plasma. J Immunol Methods 1:183\u2013193","journal-title":"J Immunol Methods"},{"key":"9533_CR37","first-page":"215","volume":"121","author":"M Wada","year":"1993","unstructured":"Wada M, Kosaka M, Saito S, Sano T, Tanaka K, Ichihara A (1993) Serum concentration and localization in tumor cells of proteasomes in patients with hematologic malignancy and their pathophysiologic significance. J Lab Clin Med 121:215\u2013223","journal-title":"J Lab Clin Med"},{"key":"9533_CR38","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1152\/ajplung.00140.2006","volume":"292","author":"SU Sixt","year":"2007","unstructured":"Sixt SU, Beiderlinden M, Jennissen HP, Peters J (2007) Extracellular proteasome in the human alveolar space: a new housekeeping enzyme? Am J Physiol Lung Cell Mol Physiol 292:1280\u20131288","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"9533_CR39","first-page":"2045","volume":"29","author":"K Egerer","year":"2002","unstructured":"Egerer K, Kuckelkorn U, Rudolph PE, R\u00fcckert JC, D\u00f6ner T, Burmester GR, Kloetzel PM, Feist E (2002) Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseases. J Rheumatol 29:2045\u20132052","journal-title":"J Rheumatol"},{"key":"9533_CR40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2362.2005.01508.x","volume":"35","author":"GA Roth","year":"2005","unstructured":"Roth GA, Moser B, Krenn C, Roth-Walter F, Hetz H, Richter S, Brunner M, Jensen-Jarolim E, Wolner E, Hoetzenecker K, Boltz-Nitulescu G, Ankersmit HJ (2005) Heightened levels of circulating 20S proteasome in critically ill patients. Eur J Clin Investig 35:399\u2013403","journal-title":"Eur J Clin Investig"},{"key":"9533_CR41","first-page":"508","volume":"24","author":"B Dziankowska-Bartkowiak","year":"2006","unstructured":"Dziankowska-Bartkowiak B, Waszczykowska E, Dziankowska-Zaboroszczyk E, de Graft-Johnson JE, Zalewska A, Luczynska M, Novak D (2006) Decreased ratio of circulatory vascular endothelial growth factor to endostatin in patients with systemic sclerosis\u2014association with pulmonary involvement. Clin Exp Rheumatol 24:508\u2013513","journal-title":"Clin Exp Rheumatol"},{"key":"9533_CR42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/jcla.20069","volume":"19","author":"M Sumi","year":"2005","unstructured":"Sumi M, Satoh H, Kagohashi K, Ishikawa H, Sekizawa K (2005) Increased serum levels of endostatin in patients with idiopathic pulmonary fibrosis. J Clin Lab Anal 19:146\u2013149","journal-title":"J Clin Lab Anal"},{"key":"9533_CR43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/jcmm.12160","volume":"18","author":"I Bochmann","year":"2014","unstructured":"Bochmann I, Ebstein F, Lehmann A, Wohlschlaeger J, Sixt SU, Kloetzel PM, Dahlmann B (2014) T lymphocytes export proteasomes by way of microparticles: a possible mechanism for generation of extracellular proteasomes. J Cell Mol Med 18:59\u201368","journal-title":"J Cell Mol Med"},{"key":"9533_CR44","first-page":"971907","volume":"2012","author":"RC Lai","year":"2012","unstructured":"Lai RC, Tan SS, Teh BJ, Sze SK, Arslan F, de Kleijn DP, Choo A, Lim SK (2012) Proteolytic potential of the MSC exosome proteome: implications for an exosome-mediated delivery of therapeutic proteasome. Int J Proteom 2012:971907","journal-title":"Int J Proteom"},{"key":"9533_CR45","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1021\/acs.jproteome.5b00770","volume":"14","author":"Y Zhu","year":"2015","unstructured":"Zhu Y, Chen X, Pan Q, Wang Y, Su S, Jiang C, Li Y, Xu N, Wu L, Lou X, Liu S (2015) A comprehensive proteomics analysis reveals a secretory path- and status- dependent signature of exosomes released from tumor-associated macrophages. J Proteom Res 14:4319\u20134331","journal-title":"J Proteom Res"},{"key":"9533_CR46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0165-2478(91)90002-R","volume":"28","author":"P Vadas","year":"1991","unstructured":"Vadas P, Pruzanski W, Stefanski E, Ellies LG, Aubin JE, Sos A, Melcher A (1991) Extracellular phospholipase A2 secretion is a common effector pathway of interleukin-1 and tumor necrosis factor action. Immunol Lett 28:187\u2013193","journal-title":"Immunol Lett"},{"key":"9533_CR47","first-page":"1162","volume":"23","author":"MK Lin","year":"1996","unstructured":"Lin MK, Farewell V, Vadas P, Bookmann AA, Keystone EC, Pruzanski W (1996) Secretory phospholipase A2 as an index of disease activity in rheumatoid arthritis. Prospective double blind study of 212 patients. J Rheumatol 23:1162\u20131166","journal-title":"J Rheumatol"},{"key":"9533_CR48","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1096\/fj.04-2842fje","volume":"19","author":"RA Claus","year":"2005","unstructured":"Claus RA, Bunck AC, Bockmeyer CL, Brunkhorst FM, L\u00f6sche W, Kinscherf R, Deigner HP (2005) Role of increased sphingomyelinase activity in apoptosis and organ failure of patients with severe sepsis. FASEB J 19:1719\u20131721","journal-title":"FASEB J"},{"key":"9533_CR49","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/eurheartj\/ehl541","volume":"28","author":"W Doehner","year":"2007","unstructured":"Doehner W, Bunck AC, Rauchhaus M, von Haehling S, Brunkhorst FM, Cicoira M, Tschope C, Ponikowski P, Claus RA, Anker SD (2007) Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow. Eur Heart J 28:821\u2013828","journal-title":"Eur Heart J"},{"key":"9533_CR50","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1074\/jbc.273.7.4081","volume":"273","author":"S Marathe","year":"1998","unstructured":"Marathe S, Schissel SL, Yellin MJ, Beatini N, Mintzer R, Willams KJ, Tabas I (1998) Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling. J Biol Chem 273:4081\u20134088","journal-title":"J Biol Chem"},{"key":"9533_CR51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/mrd.20052","volume":"68","author":"P Morales","year":"2004","unstructured":"Morales P, Pizarro E, Kong M, Jara M (2004) Extracellular localization of proteasomes in human sperm. Mol Reprod Dev 68:115\u2013124","journal-title":"Mol Reprod Dev"},{"key":"9533_CR52","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1095\/biolreprod.104.032532","volume":"71","author":"P Sutovsky","year":"2004","unstructured":"Sutovsky P, Manandhar G, McCauley TC, Caama\u00f1o JN, Sutovsky M, Thompson WE (2004) Proteasomel interference prevents zona pellucida penetration and fertilization in mammals. Biol Reprod 71:1625\u20131637","journal-title":"Biol Reprod"},{"key":"9533_CR53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2605.2000.00223.x","volume":"23","author":"C Wojcik","year":"2000","unstructured":"Wojcik C, Benchaib M, Lornage J, Czyba JC, Guerin JF (2000) Proteasomes in human spermatozoa. Int J Androl 23:169\u2013177","journal-title":"Int J Androl"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-016-9533-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10456-016-9533-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-016-9533-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T02:56:57Z","timestamp":1568602617000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10456-016-9533-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,5]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["9533"],"URL":"https:\/\/doi.org\/10.1007\/s10456-016-9533-6","relation":{},"ISSN":["0969-6970","1573-7209"],"issn-type":[{"value":"0969-6970","type":"print"},{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,5]]}}}